Insights on the Global Pruritus Therapeutic Market 2020-2024 | COVID-19 Analysis, Drivers, Restraints, Opportunities and Threats | Technavio

LONDON--(BUSINESS WIRE)--Technavio has been monitoring the pruritus therapeutic market and it is poised to grow by USD 3.63 billion during 2020-2024, progressing at a CAGR of 6% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Please Request Free Sample Report on COVID-19 Impact

Frequently Asked Questions-

• What was the value of the pruritus therapeutic market in 2019?
• Technavio says that the value of the market was USD 11.69 billion in 2019 and it is projected to reach USD 15.32 billion by 2024.

• At what rate is the market projected to grow during the forecast period 2020-2024?
• Growing at a CAGR of almost 6%, the market growth will accelerate in the forecast period of 2020-2024.

• What is the key factor driving the market?
• Increasing prevalence of pruritus is one of the key factors driving the market growth.

• Who are the top players in the market?
• Abbott Laboratories, Allergan Plc, Astellas Pharma Inc., Cipla Inc., GlaxoSmithKline Plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi, and Sun Pharmaceutical Industries Ltd. are some of the major market participants.

• Which region is expected to hold the highest market share?
• North America

• What is the year-over-year growth rate of the global market?
• The year-over-year growth rate for 2020 is estimated at 5.04%.

The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Abbott Laboratories, Allergan Plc, Astellas Pharma Inc., Cipla Inc., GlaxoSmithKline Plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi, and Sun Pharmaceutical Industries Ltd. are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Increasing prevalence of pruritus has been instrumental in driving the growth of the market.

Pruritus Therapeutic Market 2020-2024: Segmentation

Pruritus Therapeutic Market is segmented as below:

• Type
  • Renal Pruritus
  • Cholestatic Pruritus
  • Hematologic Pruritus
  • Endocrine Pruritus
  • Oncological Pruritus
• Geography
  • North America
  • Europe
  • APAC
  • ROW

To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR43185

Pruritus Therapeutic Market 2020-2024: Scope

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. Our pruritus therapeutic market report covers the following areas:

• Pruritus Therapeutic Market size
• Pruritus Therapeutic Market trends
• Pruritus Therapeutic Market analysis

This study identifies a strong pipeline of expected launches as one of the prime reasons driving the pruritus therapeutic market growth during the next few years.

Pruritus Therapeutic Market 2020-2024: Vendor Analysis

We provide a detailed analysis of vendors operating in the pruritus therapeutic market, including some of the vendors such as Abbott Laboratories, Allergan Plc, Astellas Pharma Inc., Cipla Inc., GlaxoSmithKline Plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi, and Sun Pharmaceutical Industries Ltd. Backed with competitive intelligence and benchmarking, our research reports on the pruritus therapeutic market are designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.

Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform

Pruritus Therapeutic Market 2020-2024: Key Highlights

• CAGR of the market during the forecast period 2020-2024
• Detailed information on factors that will assist pruritus therapeutic market growth during the next five years
• Estimation of the pruritus therapeutic market size and its contribution to the parent market
• Predictions on upcoming trends and changes in consumer behavior
• The growth of the pruritus therapeutic market
• Analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of pruritus therapeutic market vendors

Table of Contents:

Executive Summary

• Market Overview

Market Landscape

• Market ecosystem
• Value chain analysis

Market Sizing

• Market definition
• Market segment analysis
• Market size 2019
• Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

Market Segmentation by Type

• Market segments
• Comparison by Type
• Renal pruritus - Market size and forecast 2019-2024
• Cholestatic pruritus - Market size and forecast 2019-2024
• Hematologic pruritus - Market size and forecast 2019-2024
• Endocrine pruritus - Market size and forecast 2019-2024
• Oncological pruritus - Market size and forecast 2019-2024
• Market opportunity by Type

Customer landscape

• Overview

Geographic Landscape

• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2019-2024
• Europe - Market size and forecast 2019-2024
• APAC - Market size and forecast 2019-2024
• ROW - Market size and forecast 2019-2024
• Key leading countries
• Market opportunity by geography

Drivers, Challenges, and Trends

• Market drivers
• Market challenges
• Market trends

Vendor Landscape

• Overview
• Landscape disruption

Vendor Analysis

• Vendors covered
• Market positioning of vendors
• Abbott Laboratories
• Allergan Plc
• Astellas Pharma Inc.
• Cipla Inc.
• GlaxoSmithKline Plc
• Merck & Co. Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi
• Sun Pharmaceutical Industries Ltd.

Appendix

• Scope of the report
• Currency conversion rates for US$
• Research methodology
• List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.